Sartorius VIVASPIN 500 50,000 MWCO PES 25/BOX - 117X111X52
Prices plus VAT and plus shipping costs
Delivery time on request
- Order No.: 1284912
- Manufacturer Art. No.: VS0131
Vivaspin® centrifugal concentrators are disposable ultrafiltration devices for the concentration of biological samples. Vivaspin® 500 centrifugal filter units offer a simple, one step procedure for sample concentration with starting volumes up to 500 µl. They can effectively be used in fixed angle rotors accepting 2.2 ml centrifuge tubes. The patented vertical membrane design and thin channel filtration chamber (US 5,647,990), minimises membrane fouling and provides high speed concentrations. Vivaspin® 500 units are available with PES membrane in a wide range of molecular weight cut-offs. Concentrate recoveries of > 90% can be reached in less than 30 min. The dead stop pocket prevents concentration to dryness. High flux PES membrane High retentate recovery > 90 % Vertical membrane design for ultra fast concentration Universal rotor compatibility Safe sample concentration due to dead-stop volume Convenient concentrate recovery by pipetting Volume graduation for easy reading/monitoring Vivaspin® 500 Polyethersulfone, 50 kDa Performance Characteristics
| Time to concentrate up to 30x [min.] at 20°C | Concentrate recovery % | |
|---|---|---|
| Start volume | 500 µl | 500 µl |
| Aprotinin 0.25 mg/ml (6,500 MW) | ||
| 3,000 MWCO PES | 30 | 96 % |
| BSA 1.0 mg/ml (66,000 MW) | ||
| 5,000 MWCO PES | 15 | 96 % |
| 10,000 MWCO PES | 5 | 96 % |
| 30,000 MWCO PES | 5 | 95 % |
| IgG 0.25 mg/ml (160,000 MW) | ||
| 30,000 MWCO PES | 10 | 96 % |
| 50,000 MWCO PES | 10 | 96 % |
| 100,000 MWCO PES | 10 | 96 % |
Sartorius customers are working hard to develop and manufacture medicines that cure, prevent or stop the progression of diseases. To be successful, they rely on partners who understand their current and future challenges. For 150 years, the Sartorius brand has stood for innovative products and solutions that support the work of scientists and engineers worldwide. Satorius has increasingly focused on enabling breakthroughs in life science research and bioproduction.